{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1361699995160090368.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1007/s10067-018-3992-7"}},{"identifier":{"@type":"URI","@value":"http://link.springer.com/article/10.1007/s10067-018-3992-7/fulltext.html"}},{"identifier":{"@type":"URI","@value":"http://link.springer.com/content/pdf/10.1007/s10067-018-3992-7.pdf"}}],"dc:title":[{"@value":"Tocilizumab reduces complement C3 and C4 serum levels in rheumatoid arthritis patients"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1381699995160090368","@type":"Researcher","foaf:name":[{"@value":"Ciro Romano"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699995160090372","@type":"Researcher","foaf:name":[{"@value":"Andrea Del Mastro"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699995160090370","@type":"Researcher","foaf:name":[{"@value":"Ausilia Sellitto"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699995160090369","@type":"Researcher","foaf:name":[{"@value":"Eleonora Solaro"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699995160090371","@type":"Researcher","foaf:name":[{"@value":"Sergio Esposito"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699995160090496","@type":"Researcher","foaf:name":[{"@value":"Giovanna Cuomo"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"07703198"},{"@type":"EISSN","@value":"14349949"}],"prism:publicationName":[{"@value":"Clinical Rheumatology"}],"dc:publisher":[{"@value":"Springer Science and Business Media LLC"}],"prism:publicationDate":"2018-01-23","prism:volume":"37","prism:number":"6","prism:startingPage":"1695","prism:endingPage":"1700"},"reviewed":"false","dc:rights":["http://www.springer.com/tdm"],"url":[{"@id":"http://link.springer.com/article/10.1007/s10067-018-3992-7/fulltext.html"},{"@id":"http://link.springer.com/content/pdf/10.1007/s10067-018-3992-7.pdf"}],"createdAt":"2018-01-23","modifiedAt":"2018-05-11","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360853567450819200","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Serum complement C3 and α2-macroglobulin are potentially useful biomarkers for inflammatory bowel disease patients"}]},{"@id":"https://cir.nii.ac.jp/crid/2050588892102154624","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Tocilizumab-induced immunocomplex glomerulonephritis : a report of two cases"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1007/s10067-018-3992-7"},{"@type":"CROSSREF","@value":"10.1007/s13730-020-00478-6_references_DOI_PvLWraMgMSbyOZiYPzm9pRH5NTL"},{"@type":"CROSSREF","@value":"10.1016/j.heliyon.2021.e06554_references_DOI_PvLWraMgMSbyOZiYPzm9pRH5NTL"}]}